Related Experiment Video
Updated: Jun 9, 2026

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Comparative outcomes in intestinal atresia: a clinical outcome and pathophysiology analysis
Sathyaprasad Burjonrappa1, Elise Crete, Sarah Bouchard
1Division of Pediatric Surgery, Department of Surgery, New York Medical College, Valhalla, New York, NY 10595, USA. sathyabc@yahoo.com
Insights
Outcomes for 130 intestinal atresias show distal types are hard to diagnose prenatally. Proximal atresias have lower birth weights, and screening for anomalies is crucial for all intestinal atresia cases.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Neonatal Medicine
Background:
- Intestinal atresia is a congenital condition requiring surgical intervention.
- Understanding outcomes based on atresia location is vital for patient management.
Purpose of the Study:
- To analyze the outcomes of 130 cases of intestinal atresia treated between 1982 and 2007.
- To identify factors influencing diagnosis, treatment, and survival in different types of intestinal atresia.
Main Methods:
- Retrospective analysis of patient records.
- Data collected included atresia location, demographics, prenatal diagnosis rates, birth weight, associated anomalies, surgical procedures, time to oral feeds, re-interventions, and mortality.
- Statistical analysis using Fisher test and ANOVA.
Main Results:
- Duodenal atresia (DA) had lower birth weight (2,380.5g) compared to jejuno-ileal (JIA) and colonic atresia (CA).
- Prenatal diagnosis rates varied: 46% for DA, 41% for JIA, and 12.5% for CA.
- Mortality was zero for DA and CA, but six deaths occurred in the JIA group, often associated with severe anomalies or complications like sepsis.
Conclusions:
- Distal intestinal atresias present diagnostic challenges antenatally.
- Proximal atresias are associated with significantly lower birth weights.
- Comprehensive screening for congenital anomalies is essential in all intestinal atresia patients.
Objective:
To describe the outcomes of 130 intestinal atresias between 1982 and 2007.
Methods:
Records were analyzed for location, demographics, prenatal diagnosis, birth weight, associated anomalies, surgery, establishment of oral intake, re-interventions and mortality. Statistical analyses were performed using Fisher test and ANOVA.
Results:
There were 59 duodenal (30 male), 63 jejuno-ileal (34 male) and 8 colonic atresias (3 male). Prenatal diagnosis was established in 27 (46%) duodenal (DA), 26 (41%) jejuno-ileal (JIA) and 1 (12.5%) colonic atresias (CA). The mean birth weights, 2,380.5 g (SD 988) DA, 2,814 g (SD 755) JIA and 3,153 g (SD 527) CA were significantly different (p = 0.011). The mean gestational ages were 36, 37 and 37 weeks in DA, JIA and CA, respectively (p-NS). Associated congenital anomalies were seen in 41 (76%) DA, 32 (52%) JIA and 3 (38%) CA (p = 0.08, NS). The median time to full oral feeds after surgery was 18 days in DA, 20 days in JIA and 15.6 days in CA, respectively (p > 0.05). Eight patients with DA and nine patients with JIA underwent repeat surgery for adhesive obstruction. Adhesive bowel obstruction was most common in the first year after surgery in both groups (15/17). Gastroschisis was seen in six (10%) of JIA and three (35%) of CA. Two patients in the JIA group underwent bowel lengthening. Patients with gastroschisis and those with associated anomalies needed prolonged duration of TPN after JIA correction. There was no mortality in the duodenal atresia and colonic atresia groups. Six patients in the JIA group died, three of severe atresias coupled with multiple anomalies and three of cholestasis and sepsis.
Conclusion:
Distal atresias are difficult to diagnose antenatally. Proximal atresias have a significantly lower birth weight than distal atresias. Associated anomaly screening is important in all atresias.
Related Concept Videos
Intestinal Obstruction II: Pathophysiology
Intestinal Obstruction I: Introduction
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

